Home | My Profile | Contact Us
Research Trends Products  |   order gateway  |   author gateway  |   editor gateway  
Register | Forgot Password

Author Resources
 Author Gateway
 Article submission guidelines

Editor Resources
 Editor/Referee Gateway

 Regional Subscription Agents/Distributors
Current Topics in Toxicology   Volumes    Volume 2 
Therapeutic immunosuppressant use during pregnancy: potential for developmental immunotoxicity
R. M. Gogal Jr., B. L. Blaylock, S. D. Holladay
Pages: 41 - 48
Number of pages: 8
Current Topics in Toxicology
Volume 2 

Copyright © 2005 Research Trends. All rights reserved

Impaired postnatal immune responses may result from fetal and early postnatal exposure to immunosuppressive drugs. Beyond immune suppression, there is concern that perinatal immunosuppressant exposure may exacerbate postnatal aberrant immune responses (e.g., autoimmune disease). Limited human data, especially post-pubertal data, are available that examine immune capacity after developmental immunotoxicant exposure. The multifactorial nature of hypersensitivity and autoimmune responses, in particular, will complicate elucidation of possible relationships between drug exposure during ontogeny of the human immune system and these immune-mediated diseases later in life. However, the use of potent therapeutic immunosuppressants during pregnancy has been increasing over the past several decades. It will be important that these children be followed to identify possible long-term adverse effects from such exposures during immune system establishment.
Buy this Article


Buy this article
Buy this volume
Subscribe to this title
Shopping Cart

Quick Links
Search Products
Browse in Alphabetical Order : Journals
Browse by Subject Classification : Journals

Ordering Information Ordering Information
Downloadable forms Downloadable Forms